Back to Menu
Gallbladder cancer originates from the gallbladder mucosa and is most commonly adenocarcinoma. Although relatively uncommon, it is highly aggressive and readily invades the liver and regional lymph nodes. Early symptoms are often nonspecific, while advanced disease may present with jaundice, abdominal pain, and weight loss. Prognosis is closely associated with disease stage.
1. Adenocarcinoma
The most common histologic type, accounting for >85% of cases, with multiple subtypes including intestinal, gastric, and biliary phenotypes.
2. Squamous cell carcinoma
A relatively rare type arising from squamous metaplasia of the gallbladder mucosa, with biological behavior distinct from adenocarcinoma.
3. Adenosquamous carcinoma
Contains both glandular and squamous components and is typically highly invasive with a poor prognosis.
4. Undifferentiated carcinoma
Extremely aggressive with rapid tumor growth; most patients are diagnosed at an advanced stage.
5. Rare types
Include neuroendocrine carcinoma and sarcoma; incidence is very low and management requires individualized strategies.
6. Classification by growth pattern
Includes infiltrative, nodular, and papillary patterns; papillary adenocarcinoma generally has a relatively better prognosis.
1. Gallstones
The most important risk factor; approximately 85% of patients have cholelithiasis, and chronic mucosal irritation promotes malignant transformation.
2. Gallbladder polyps
Polyps >1 cm have a higher risk of malignant transformation and require surveillance and timely intervention.
3. Chronic cholecystitis
Chronic inflammatory conditions such as porcelain gallbladder are strongly associated with carcinogenesis through long-term irritation.
4. Congenital choledochal cysts
Patients with congenital biliary cysts have increased gallbladder cancer risk due to bile stasis and chronic epithelial injury.
5. Obesity and dietary factors
Obesity and high-fat diet may increase risk through hormonal and inflammatory mechanisms.
6. Bacterial infection
Chronic Salmonella typhi carriage is associated with increased gallbladder cancer risk via persistent infection and mucosal damage/repair.
7. Age and sex
Incidence is higher in women and in individuals older than 65 years; estrogen may contribute to tumorigenesis.
8. Primary sclerosing cholangitis
A recognized risk factor, with chronic inflammatory milieu promoting malignant transformation.
1. Gallstone management
Treat symptomatic gallstones promptly, monitor asymptomatic stones, control body weight, and avoid rapid weight loss.
2. Dietary modification
Adopt a low-fat, high-fiber diet; increase fruit and vegetable intake; limit alcohol; eat regularly and avoid skipping breakfast.
3. Regular health examinations
High-risk individuals should undergo periodic abdominal ultrasonography; gallbladder polyps >1 cm should be managed proactively.
4. Risk factor control
Control body weight to avoid obesity, treat chronic gallbladder inflammation actively, and manage metabolic syndrome.
5. Healthy lifestyle
Maintain regular moderate physical activity, avoid smoking, limit alcohol, keep healthy sleep patterns, and minimize exposure to carcinogenic chemicals.
Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes that gallbladder cancer is highly malignant with poor prognosis and poses a serious threat to life. Because early disease is often silent, many patients are no longer candidates for surgery at diagnosis. High-risk populations should undergo regular screening and seek prompt medical evaluation when symptoms occur. MDT-based collaboration and individualized treatment planning are key to improving outcomes, and patients are encouraged to maintain confidence and actively participate in care.
Gallbladder cancer originates from the gallbladder mucosa and is most commonly adenocarcinoma. Although relatively uncommon, it is highly aggressive and readily invades the liver and regional lymph nodes. Early symptoms are often nonspecific, while advanced disease may present with jaundice, abdominal pain, and weight loss. Prognosis is closely associated with disease stage.
1. Adenocarcinoma
The most common histologic type, accounting for >85% of cases, with multiple subtypes including intestinal, gastric, and biliary phenotypes.
2. Squamous cell carcinoma
A relatively rare type arising from squamous metaplasia of the gallbladder mucosa, with biological behavior distinct from adenocarcinoma.
3. Adenosquamous carcinoma
Contains both glandular and squamous components and is typically highly invasive with a poor prognosis.
4. Undifferentiated carcinoma
Extremely aggressive with rapid tumor growth; most patients are diagnosed at an advanced stage.
5. Rare types
Include neuroendocrine carcinoma and sarcoma; incidence is very low and management requires individualized strategies.
6. Classification by growth pattern
Includes infiltrative, nodular, and papillary patterns; papillary adenocarcinoma generally has a relatively better prognosis.
1. Gallstones
The most important risk factor; approximately 85% of patients have cholelithiasis, and chronic mucosal irritation promotes malignant transformation.
2. Gallbladder polyps
Polyps >1 cm have a higher risk of malignant transformation and require surveillance and timely intervention.
3. Chronic cholecystitis
Chronic inflammatory conditions such as porcelain gallbladder are strongly associated with carcinogenesis through long-term irritation.
4. Congenital choledochal cysts
Patients with congenital biliary cysts have increased gallbladder cancer risk due to bile stasis and chronic epithelial injury.
5. Obesity and dietary factors
Obesity and high-fat diet may increase risk through hormonal and inflammatory mechanisms.
6. Bacterial infection
Chronic Salmonella typhi carriage is associated with increased gallbladder cancer risk via persistent infection and mucosal damage/repair.
7. Age and sex
Incidence is higher in women and in individuals older than 65 years; estrogen may contribute to tumorigenesis.
8. Primary sclerosing cholangitis
A recognized risk factor, with chronic inflammatory milieu promoting malignant transformation.
1. Gallstone management
Treat symptomatic gallstones promptly, monitor asymptomatic stones, control body weight, and avoid rapid weight loss.
2. Dietary modification
Adopt a low-fat, high-fiber diet; increase fruit and vegetable intake; limit alcohol; eat regularly and avoid skipping breakfast.
3. Regular health examinations
High-risk individuals should undergo periodic abdominal ultrasonography; gallbladder polyps >1 cm should be managed proactively.
4. Risk factor control
Control body weight to avoid obesity, treat chronic gallbladder inflammation actively, and manage metabolic syndrome.
5. Healthy lifestyle
Maintain regular moderate physical activity, avoid smoking, limit alcohol, keep healthy sleep patterns, and minimize exposure to carcinogenic chemicals.
Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes that gallbladder cancer is highly malignant with poor prognosis and poses a serious threat to life. Because early disease is often silent, many patients are no longer candidates for surgery at diagnosis. High-risk populations should undergo regular screening and seek prompt medical evaluation when symptoms occur. MDT-based collaboration and individualized treatment planning are key to improving outcomes, and patients are encouraged to maintain confidence and actively participate in care.